Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes

Atherosclerosis

Volumn 147, Issue 2, 1999, Pages 297-307

  Wu, Dayong ^a   Koga, Takuro ^a   Martin, Keith R ^a   Meydani, Mohsen ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Adhesion molecule; Chemokine; Endothelial cell; IL 6; IL 8; MCP 1; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

AORTA; ARTICLE; ATHEROGENESIS; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG UPTAKE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANALYSIS OF VARIANCE; AORTA; CELL ADHESION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; E-SELECTIN; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTES; SENSITIVITY AND SPECIFICITY; VASCULAR CELL ADHESION MOLECULE-1; VITAMIN E;

EID: 0032740397     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00199-9     Document Type: Article

References (68)

1. Collins T. Biology of disease: Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab. Invest. 68:1993;499-508.
2. Cybulski M.I., Gimbrone M.A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherosclerosis. Science. 251:1991;788-791.
3. Li H., Cybulsky M.I., Gimbrone M.A., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Artherioscler. Thromb. 13:1993;197-204.
4. van der Wal A.C., Das P.K., Tigges A.J., Becker A.E. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am. J. Pathol. 141:1992;1427-1433.
5. Davies M.J., Gordon J.L., Gearing A.J., Pigott R., Woolf N., Katz D., Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171:1993;223-229.
6. Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB. 4:1990;2860-2867.
7. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem. J. 265:1990;621-636.
8. Lukacs N.W., Strieter R.M., Elner V., Evanoff H.L., Burdick M.D., Kunkel S.L. Production of chemokines, interleukin-8, and monocyte chemoattractant protein-1, during monocyte:endothelial cell interactions. Blood. 86:1995;2767-2773.
9. Aarden L., Helle M., Boeije L., Pascual-Salcedo D., de Groot E. Differential induction of interleukin-6 production in monocytes, endothelial cells and smooth muscle cells. Eur. Cytokine Net. 2:1991;115-120.
10. Ala Y., Palluy O., Favero J., Bonne C., Modat G., Dornand J. Hypoxia/reoxygenation stimulates endothelial cells to promote interleukin-1 and interleukin-6 production. Effects of free radical scavengers. Agent Action. 37:1992;134-139.
11. Watson C., Whittaker S., Smith N., Vora A.J., Vora D.C.D., Brown K.A. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin. Exp. Immunol. 105:1996;112-119.
12. Carr M.W., Roth S.J., Luther E., Rose S.S., Springer T.A. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA. 91:1994;3652-3656.
13. Oppenheim J.J., Zachariae C.O.C., Mukaida N., Matsushima K. Properties of the novel pro-inflammatory 'intercrine' cytokine family. Annu. Rev. Immunol. 9:1991;617-648.
14. Valente A.J., Graves D.T., Vialle-Valentin R., Delgado R., Schwartz C.J. Purification of monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry. 27:1988;4162-4168.
15. Nelken N.A., Coughlin S.R., Gordon D., Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1991;1121-1127.
16. Takeya M., Yoshimura T., Leonhard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 antibody. Human Pathol. 24:1993;534-539.
17. -/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
18. Springer T.A. Traffic signals for lymphocyte emigration: the multistep paradigm. Cell. 76:1994;301-314.
19. Gaziano J.M., Manson J., Buring J.E., Hennekens C.H. Dietary antioxidants and cardiovascular disease. Ann. N.Y. Acad. Sci. 669:1992;249-259.
20. Gey K.F., Stahelin H.B., Eichholser M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Panel Prospective Study. J. Clin. Invest. 71:1993;3-6.
21. Meydani M. Antioxidant Vitamins. Frontier. Clin. Nutr. 4:1995;7-14.
22. Hodis H.N., Mack W.J., LaBree L., Cashin-Hemphill L., Sevanian A., Johnson R., Azen A.P. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. J. Am. Med. Assoc. 273:1995;1849-1854.
23. Meydani M., Vitamin E. Lancet. 345:1995;170-175.
24. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
25. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328:1993;1444-1449.
26. Packer L. Vitamin E: Biological activity and health benefits: overview. In: Packer L, Fuchs J, editors. Vitamin E in Health and Disease. New York: Marcel Dekker, 1992:977-982.
27. Jialal I., Fuller C.J., Huet B.A. The effect of alpha-tocopherol supplementation on LDL oxidation. Arterioscler. Thromb. Vasc. Biol. 15:1995;190-198.
28. Steiner M. Vitamin E: more than an antioxidant. Clin. Cardiol. 16:1993;16-18.
29. Azzi A, Boscoboinik D, Marilley D, Ozer NK, Stable B, Tasinato A. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am J Clin Nutr 1995;62 Suppl 6:1337S-1346S.
30. Faruqi R., de la Motte C., DiCorelto P.E. Tocopherol inhibits against induced monocytic cell adhesion to cultured human endothelial cells. J. Clin. Invest. 94:1994;592-600.
31. Devaraj S., Li D., Jialal I. The effects of alpha tocopherol supplementation on monocyte function: Decreased lipid oxidation, interleukin 1β secretion, and monocyte adhesion to endothelium. J. Clin. Invest. 98:1996;756-763.
32. Islam K.N., Devaraj S., Jialal I. alpha-Tocopherol enrichment of moncytes decreases agonist-induced adhesion to human endothelial cells. Circulation. 98:1998;2255-2261.
33. Martin A., Foxall T., Blumberg J.B., Meydani M. Vitamin E inhibits low density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscl. Thromb. Vasc. Biol. 17:1997;429-436.
34. Martin A., Wu D., Baur W., Meydani S.N., Blumberg J.B., Meydani M. Effect of vitamin E on aortic endothelial cell responses to oxidative injury. Free Rad. Biol. Med. 21:1996;505-511.
35. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351:1998;88-92.
36. DiCorleto P.E., de la Motte C.A. Characterization of the adhesion of human monocytic cell line U937 to culture endothelial cells. J. Clin. Invest. 75:1985;1153-1161.
37. Meydani M., Meisler J.G. A Closer Look at Vitamin E. Postgrad. Med. 102:1997;199-207.
38. Meydani M, Fielding RA, Fotouhi N. Vitamin E. In: Wolinsky I, Driskell JA, editors. Sports Nutrition: Vitamins and Trace Elements. New York: CRC Press, 1996:119-135.
39. Gey K.F., Brubacher G.B., Stahelin H.B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am. J. Clin. Nutr. 45:1987;1368-1377.
40. Kushi L.H., Folsom A.R., Prineas R.J., Mink P.J., Wu Y., Bostock R.M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334:1996;1156-1162.
41. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Chessman K., Mitchinson M.J., Brown M.J. Randomized, controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
42. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond Cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
43. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
44. Reaven P.D., Witztum J.L. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Ann. Rev. Nutr. 16:1996;51-71.
45. Martin A., Wu D., Meydani S.N., Blumberg J.B., Meydani M. Vitamin E prevents oxidized LDL-induced cytotoxic injury to human aortic endothelial cells in vitro. J. Nutr. Biochem. 9:1998;201-208.
46. Ozer N.K., Palozza P., Boscoboninik D., Azzi A. D-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett. 322:1993;307-310.
47. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A. D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. 92:1995;12190-12194.
48. Cai J.-P., Hudson S., Ye M.-W., Chin Y.-H. The intracellular signaling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium. Cell. Immunol. 167:1996;269-275.
49. Larsen C.G., Anderson A.O., Appella E., Oppenheim J.J., Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science. 243:1989;1464-1466.
50. Navab M., Imes S.S., Hough G.P. et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein I synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88:1991;2039-2046.
51. Meydani S.N., Meydani M., Blumberg J.B. et al. Vitamin E supplementation enhances in vivo immune response in healthy elderly: A dose-response study. J. Am. Med. Assoc. 277:1997;1380-1386.
52. Takahashi M., Ikeda U., Kasahara T. et al. Activation of human monocytes for enhanced production of interleukin 8 during transendothelial migration in vitro. J. Clin. Immunol. 17:1997;53-62.
53. Nakae H., Endo S., Inada K., Kasai T., Yoshida M. Significance of alpha-tocopherol and interleukin-8 in septic adult respiratory distress syndrome. Res. Commun. Chem. Pathol. Pharmacol. 84:1994;197-202.
54. Yokota T., Hansson G.K. Immunological mechanisms in atherosclerosis. J. Intern. Med. 238:1995;479-489.
55. Bell L., Madri J.A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65:1989;1057-1065.
56. Ikeka U., Ikeda M., Oohara T. et al. IL-6 stimulates growth of vascular SMC in a PDGF-dependent manner. Am. J. Physiol. 260:1991;H1713-1717.
57. Basha B.J., Sowers J.R. Atherosclerosis: An update. Am. Heart J. 131:1995;1192-1202.
58. Libby P., Hansson G.K. Biology of disease. Involvement of the immune system in human atherogenesis. Current knowledge and unanswered questions. Lab. Invest. 64:1991;5-15.
59. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:1995;791-804.
60. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:1995;899-909.
61. Neish A.S., Williams A.J., Palmer H.J., Whitley M.Z., Collins T. Functional analysis of the human vascular cell adhesion molecule 1 promotor. J. Exp. Med. 176:1992;1583-1593.
62. Vorarberger G., Schafer R., Strotowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′ regulatory region. J. Immunol. 147:1991;2777-2786.
63. Whelan J., Ghersa P., Hooft van Huijsduinen R., Gray J., Chandra G., Talabot F., DeLamarter J.F. An NF-κB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule (ELAM) gene transcription. Nucl. Acids Res. 19:1991;2645-2653.
64. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
65. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-κB, and glutatione s-transferase gene expression. J. Biol. Chem. 271:1996;13422-13429.
66. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB. EMBO J. 10:1991;2247-2258.
67. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
68. Kaneko M., Hayashi J., Saito I., Miyasaka N. Probucol downregulates E-selectin expression on cultured human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 16:1996;1047-1051.